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Relationship between hypertension, diabetes and proteinuria
in rural and urban households in Yemen
PA Modesti1,2, M Bamoshmoosh3, S Rapi1, L Massetti1, S Bianchi4, D Al-Hidabi3 and H Al Goshae3
Little information is available on the meanings of proteinuria in low-resource settings. A population-based, cross-sectional survey
was performed in Yemen on 10 242 subjects aged 15–69 years, stratified by age, gender and urban/rural residency. Hypertension is
defined as systolic blood pressure (BP) of X140mmHg and/or diastolic BP of X90mmHg, and/or self-reported use of
antihypertensive drugs; diabetes is diagnosed as fasting glucose of X126mgdl 1 or self-reported use of hypoglycaemic
medications; proteinuria is defined as Xþ 1 at dipstick urinalysis. Odds ratios (ORs) for associations were determined by
multivariable logistic regression models. Prevalence (weighted to the Yemen population aged 15–69 years) of hypertension,
diabetes and proteinuria were 7.5, 3.7 and 5.1% in urban, and 7.8, 2.6 and 7.3% in rural locations, respectively. Proteinuria and
hypertension were more prevalent among rural dwellers (adjusted ORs 1.56; 95% confidence limit (Cl) 1.31–1.86, and 1.23;
1.08–1.41, respectively), diabetes being less prevalent in rural areas (0.70; 0.58–0.85). Differently from hypertension and diabetes,
proteinuria was inversely related with age. Most importantly, 4.6 and 6.1% of urban and rural dwellers, respectively, had proteinuria
in the absence of hypertension and diabetes. The approach of considering kidney damage as a consequence of hypertension and
diabetes might limit the effectiveness of prevention strategies in low-income countries.
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INTRODUCTION
The major causes of death and disability in developing countries
are now shifting from a predominance of nutritional deficiencies
and infectious diseases to cardiovascular disease.1 Changes in
lifestyle and diet habits following urbanization are indeed greatly
contributing to increased obesity, diabetes and dyslipidemia.2
Likewise, increased salt and alcohol intake in urban areas are the
major risk factors for high blood pressure (BP).3,4 These global
changes are now expected to increase also the potential health
burden of kidney damage.5 The common risk factors shared by
kidney damage and cardiovascular diseases support the focus on
diabetes and hypertension as an adequate strategy to deal with
kidney damage also in the developing countries.5 In low-income
countries, infectious diseases may however add substantial
burden to non-communicable risk factors in enhancing the
global prevalence of chronic kidney disease.6–10 Proteinuria is a
recognized early marker of kidney damage and a risk factor to
develop chronic kidney disease, and eventually end-stage renal
disease (ESRD).11 In a meta-analysis of more than 1.1 million
individuals aged 42–81 years,12 dipstick proteinuria of 1þ or
greater conferred also an increased risk for all-cause mortality,
independently of age and estimated glomerular filtration rate. The
evaluation of the different meanings of proteinuria in urban and
rural settings is however rarely addressed in scientific literature.
This information may have relevant clinical implications, because
in low-income countries the possibility to treat ESRD may be
limited, although early detection and treatment of subjects with
proteinuria using readily available, inexpensive therapies can slow
down or prevent progression to ESRD.13 Furthermore, the
possibility to focus antihypertensive treatment on high-risk
subjects might thus have potential implications for health-care
resource allocation in low-resource settings.14
Yemen is characterized by a highly traditional lifestyle and a low
prevalence of hypertension, as observed in two limited surveys
conducted in the capital area.15,16 The country may thus represent
an ideal scenario to investigate the interaction between
urbanization, non-communicable disease (hypertension and
diabetes) and proteinuria. Hypertension and Diabetes in Yemen
(HYDY) project was thus designed to investigate, with a door-to-
door approach, the prevalence of diabetes, hypertension,
proteinuria and their relationships, both in rural and urban
residents of Yemen.
MATERIALS AND METHODS
Study sites and study population
A multistage stratified sampling method was used as previously
reported.14 Briefly in the first stage, Yemen was stratified into three
regions, the capital area, the inland and the coastal area. The governorate
of Sana’a (capital area), the governorate of Taizz (inland) and the
governorates of Al Hudaydah and Hadramaut (coast) were selected to
be representatives of the geographic, economic and climatic
characteristics of the three regions. In the second stage, rural and urban
regions were identified from each study area. In the third stage, districts
were arbitrarily identified within each urban and rural region, boundaries
being defined using local maps or in consultation with the local health
workers. The total number of districts within each study area (20 in the
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capital area, 12 in the inland and 8 in the coastal area) was proportional to
the estimated population size of the area. In the final stage, due to the lack
of a national population register,17 250 adult participants from each district
were allocated to a cluster stratified by gender and age decades (15–24
years; 25–34; 35–44; 45–54; 55–69) to a total of 10 000 individuals allocated
into 10 strata. The study was approved by the Ethical Committee of the
University of Science and Technology, Sana’a, Yemen. Informed verbal
consent was obtained from every participant before data collection.
Data collection
The survey was performed following the three different levels, which
included questionnaire, physical measurements and biochemical measure-
ments, as previously reported.14 Briefly, the burden of hypertension and
diabetes in the population was assessed by taking BP and fasting glucose
(FG) measurements on two visits, separated by a median interval of 5.36
days (95% confidence limit (Cl) 5.30–5.42; range 1–13 days).14 Data
collection was conducted at home by centrally trained survey teams
composed of two investigators of the opposite gender.
During the first visit (visit 1), study questionnaire was administered after
obtaining consent. Study questionnaire included questions about demo-
graphics, lifestyle and medical history.14 Three measurements of systolic
(SBP) and diastolic (DBP) pressure and pulse rate were taken 2min apart on
dominant arm after a rest of at least 15min in the seated position.18
Readings were obtained with a clinically validated semiautomatic
sphygmomanometer (HEM 705 IT; Omron Matsusaka Co, Ltd, Matsusaka,
Japan) using appropriate cuff size. The averages of the last two readings
for SBP and DBP were defined as SBP1 and DBP1, respectively.
Anthropometric measurements were taken on standing participants
wearing light clothing and without shoes by using standard
techniques.18 Body weight was measured to the nearest 0.1 kg using a
spring balance, and height to the nearest 0.5 cm using a stadiometer. Waist
and hip circumference was measured to the nearest 0.1 cm. Finger-prick
blood samples were then obtained from fasting (48 h) subjects to
measure FG (Accutrend system, Roche Diagnostics, Mannheim, Germany),
cholesterol and triglyceride blood values (MultiCare-in, Biochemical System
International, Arezzo, Italy).19 A urine sample was collected and a dipstick
test (Auction sticks, A Menarini Diagnostics, Florence, Italy)20 was
immediately performed, results being decided by careful visual
comparison of the test strip with a color chart provided on the bottle
label. A new appointment was taken for non-fasting participants.
All subjects were then visited again within the next 10 days by the same
survey team, using the same measurement devices and procedures for the
second session of BP (SBP2 and DBP2) and fasting glucose (FG2)
measurements.
Diagnostic criteria and definition of variables
Measures have been taken to attain complete reliability and to reduce the
variation to reasonable limits. All the study personnel successfully
completed the specific 1-week training program organized in Sana’a
(December 2007) on the aims of the study and the specific methods used
to standardize the procedure for sampling and contacting individuals,
questionnaire administration and form filling, BP measurements using
electronic devices, performing blood biochemical assay, performing urine
assay and data entry into computerized database. The training program
included a pilot testing performed on a population sample of 400
individuals in urban and rural areas of Sana’a.
Arterial hypertension was defined as (1) SBP1 and SBP2 X140mmHg
and/or DBP1 and DBP2 X90mmHg and/or, (2) self-reported use of
antihypertensive drugs at the time of the interview.18 Diabetes was
defined as (1) FG X126mgdl 1 at both the visits or, (2) self-reported use
of hypoglycaemic medications at the time of the interview.21 Overweight
and obesity were defined as a body mass index of 25.0–29.9 kgm 2, and
X30 kgm 2, respectively. Abdominal obesity was defined as waist
circumference 4102 cm in men and 488 cm in women. On the basis of
cholesterol and triglycerides assessments, subjects were classified as high
cholesterol (4190mgdl 1) or high triglycerides (4150mgdl 1).18
Results of dipstick urinalysis were recorded as follows: (1) urinary
proteins: negative (0), trace (þ / ) or proteinuria (1þ , 2þ , 3þ or
4þ ). Reliability of measurements performed by visual inspection of strips
was previously assessed.20 On the basis of education level, subjects were
classified into six categories: (1) illiterate; (2) can read and write; (3) primary
school; (4) secondary school; (5) high school and (6) college or post.
Daily smokers and daily khat users were defined as those who smoked
tobacco or chewed khat on a daily basis. Fruit and vegetable consumption
were classified as (1)p1 day per week; (2) 2–4 days per week; (3)X5 days
per week. Participants were categorized as sedentary when self-reporting
vigorous physical exercise (job, sport or recreational activities) foro10min
daily.
Statistical methods
Description and validation of the database can be found elsewhere.22
Prevalence estimates were calculated for the five age groups in the overall
population and by gender. All calculations were weighted to represent the
total Yemen population aged 15–69 years. Weights were calculated on the
basis of age- and gender-stratified data from the year 2008-estimated
Yemen population.17 Additionally, to allow a direct comparison with
prevalence data obtained in other countries, prevalence was also age
standardized to the World Health Organization’s World Standard
Population for age ranges 15–69 and 35–69 years.23 Data are expressed
as mean with 95% Cl for continuous variables, and as rates with 95% Cl for
categorical variables.
Unadjusted odds ratios (ORs) between exposure variables and urban/
rural location were determined by using univariate logistic regression
analysis.
Factors associated with hypertension awareness or pharmacologic
treatment were investigated by logistic regression analysis in the subgroup
of subjects diagnosed with hypertension. Factors associated with BP drug
control were investigated in the subgroup of 528 hypertensive subjects
treated with antihypertensive drugs. Age, gender, urban/rural location,
education categories and proteinuria were included as independent
variables.
Factors independently associated with proteinuria were investigated at
multivariate logistic regression analysis to evaluate the simultaneous effect
of the various exposure variables, with adjustment for any confounding
variables. Variables included in the model were age, gender, location, level
of education, self-reported sedentary lifestyle, daily smoking, daily khat use,
categories of vegetable and fruit consumption, hypertension, diabetes, high
cholesterol, high triglycerides, obesity and abdominal obesity.
Differences between urban and rural dwellers were investigated at
logistic regression analysis with urban/rural residency as dependent
variable, and age, gender, level of education, self-reported sedentary
lifestyle, daily smoking, daily khat use, categories of fruit and vegetable
consumption, hypertension, diabetes, high cholesterol, high triglycerides,
obesity, abdominal obesity and proteinuria as independent variables.
The independent association of proteinuria with hypertension and
diabetes was separately tested among urban and rural residents.
Comparisons were performed using two models of logistic regression
including proteinuria as dependent variable, with hypertension, diabetes,
urban/rural location, age, gender, education categories included as
independent variables (model 1). Model 2 included also high cholesterol,
obesity and abdominal obesity as independent variables.
Results are expressed as OR with 95% Cl. Test of hypothesis was done at
a significance level of 0.05 (two-sided). Statistical Package for the Social
Sciences software version 19.0 (SPSS, Chicago, IL, USA), was used for
statistical analyses.
RESULTS
The survey was completed within 16 months, with an overall
response rate of 92 and 94% in urban and rural locations,
respectively. Response rate did not differ by age or gender. The
numbers of included participants stratified by age, gender and
urban/rural location are reported as Supplementary Data Table 1S.
Main characteristics of the 10 242 participants (5063 male and
5179 female participants) are reported in Table 1. Overall, 51.5% of
the women and 19.5% of the men were illiterate, differences
being higher in rural than in urban settings (see Supplementary
Data Table S2).
Prevalence and urban/rural distribution of risk factors
Age-weighted prevalence of the main risk factors in the overall
population, and in rural and urban householders is reported in
Table 2. For prevalence of age standardized to the World Health
Organization’s World Standard Population for age ranges of 15–69
and 35–69 years, see Supplementary Table S3. Obesity, abdominal
obesity and high cholesterol were more prevalent in women than
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in men, no differences being observed for diabetes. Overall, 1307
participants fulfilled the criteria of hypertension, prevalence being
higher among women than men (OR 1.22; 95% Cl 1.01–1.37).
Hypertension awareness, allocation to treatment and achievement
of drug control were more prevalent in women than in men
(Table 3). After adjustment for age and level of education, women
gender was no more associated with hypertension diagnosis
(adjusted OR 1.09; 0.96–1.24), whereas prevalence of obesity
(adjusted OR 2.13; 1.86–2.44), abdominal obesity (adjusted OR
11.45; 9.69–13.54) and high cholesterol (adjusted OR 1.41; 1.25–
1.58) remained higher in women than in men.
Obesity, abdominal obesity, high cholesterol and diabetes were
less prevalent in rural than in urban residents in the overall
population, and by gender (Table 2). After adjustment for age,
gender, education categories, diabetes, high cholesterol, obesity
and abdominal obesity, hypertension was more prevalent in rural
than in urban locations (Table 2). Hypertension awareness and
allocation to antihypertensive treatment were also more prevalent
among urban residents (Table 3).
Prevalence and urban/rural distribution of indicators of chronic
kidney damage
The presence of urinary protein (trace or more) at dipstick test was
more prevalent among rural (1366 out of 4925) than among urban
dwellers (895 out of 5100) (w2 33.12; Po0.001). More precisely,
654, 179, 44, 1 and 4 urban dwellers had protein trace, 1þ , 2þ ,
3þ and 4þ , respectively. Conversely, 998, 263, 71, 27 and 7 rural
dwellers had protein trace, 1þ , 2þ , 3þ and 4þ at dipstick test,
respectively. Overall, 6.2% of Yemen population aged 15–69 years
had proteinuria (X1þ ) at dipstick test (Table 2), proteinuria being
more prevalent in rural (7.3%) than in urban residents (5.1%) (OR
1.63; 1.38–1.93) (Table 2). Conversely, the presence of glucose
(trace or more) in urinary samples was more prevalent among
urban (490 out of 5097) than among rural dwellers (417 out of
5120; w2 6.81, Po0.01). The amount of overlap between
hypertension, diabetes and proteinuria among urban and rural
dwellers is shown in Figure 1.
The independent association of proteinuria with rural setting
was confirmed after further adjustment for diet habits (vegetable
and fruit consumption), self-reported sedentary lifestyle, daily
smoking, obesity, abdominal obesity, high cholesterol, hyperten-
sion and diabetes (logistic regression analysis including 9384
participants) (Figure 2). More precisely, on performing adjusted
logistic regression, proteinuria, divided into six categories (none,
trace, þ 1, þ 2, þ 3 and þ 4), remained the only investigated risk
condition more prevalent in rural than in urban areas (Figure 3).
To further investigate the interaction of proteinuria with
hypertension and diabetes, logistic regression was separately
performed in urban and rural residents (Table 4). After adjustment
with different models, proteinuria was associated with hyperten-
sion both in urban and rural locations, whereas diabetes was
Table 1. Characteristics of participants
Variables All Urban Rural
n Mean (95% Cl) n Mean (95% Cl) n Mean (95% Cl)
All
Education (years) 10 235 7.7 (7.5–7.9) 5106 8.3 (8.0–8.6) 5129 7.1 (6.8–7.4)
BMI (kgm 2) 10 205 22.9 (22.7–23.1) 5089 23.3 (23.1–23.6) 5116 22.4 (22.2–22.7)
Hip (cm) 10 202 88.6 (88.1–89.2) 5079 90.2 (89.4–91.0) 5123 87.1 (86.4–87.9)
W/H ratio 10 202 0.864 (0.868–0.861) 5079 0.861 (0.866–0.855) 5123 0.868 (0.873–0.863)
SBP (mmHg) 10 232 118.9 (118.3–119.4) 5104 119.0 (118.2–119.8) 5128 118.8 (118.0–119.6)
DBP (mmHg) 10 227 74.7 (74.3–75.1) 5099 74.9 (74.4–75.4) 5128 74.5 (74.0–75.0)
FG (mgdl 1) 10 181 85.4 (84.5–86.3) 5083 85.9 (84.5–87.2) 5098 85.0 (83.6–86.5)
TC (mgdl 1) 10 138 79.3 (75.8–82.7) 5064 91.3 (86.2–96.3) 5074 67.3 (62.6–71.9)
TG (mgdl 1) 10 127 139.1 (136.4–142.6) 5058 145.3 (140.8–149.7) 5069 133.7 (129.3–140.8)
Men
Education (years) 5058 9.4 (9.1–9.6) 2516 9.6 (9.3–10.0) 2542 9.1 (8.7–9.5)
BMI (kgm 2) 5041 22.3 (22.0–22.5) 2506 22.7 (22.3–23.1) 2535 21.9 (21.5–22.2)
Hip (cm) 5041 86.6 (85.8–87.3) 2503 87.8 (86.7–89.0) 2538 85.3 (84.4–86.3)
W/H ratio 5041 0.879 (0.884–0.874) 2503 0.882 (0.890–0.874) 2538 0.877 (0.884–0.870)
SBP (mmHg) 5056 119.3 (118.5–120.1) 2515 120.1 (119.0–121.2) 2541 118.5 (117.5–119.5)
DBP (mmHg) 5053 74.5 (74.0–75.0) 2512 75.2 (74.5–75.8) 2541 73.8 (73.1–74.5)
FG (mgdl 1) 5028 84.1 (82.8–85.4) 2498 84.5(82.7–86.1) 2530 83.9 (82.1–85.7)
TC (mgdl 1) 5014 71.5 (66.9–76.2) 2493 83.9 (76.9–90.5) 2521 59.5 (53.4–66.1)
TG (mgdl 1) 5009 141.7 (136.0–147.0) 2488 148.8 (143.5–155.0) 2521 135.5 (129.3–140.8)
Women
Education (years) 5177 6.1 (5.8–6.4) 2590 7.1 (6.7–7.5) 2587 5.2 (4.8–5.6)
BMI (kgm 2) 5164 23.4 (23.2–23.7) 2583 24.0 (23.5–24.4) 2581 22.9 (22.6–23.3)
Hip (cm) 5161 90.7 (89.9–91.5) 2576 92.5 (91.3–93.7) 2585 88.9 (87.9–90.0)
W/H ratio 5161 0.850 (0.856–0.845) 2576 0.841 (0.849–0.833) 2585 0.859 (0.867–0.852)
SBP (mmHg) 5176 118.5 (117.8–119.3) 2589 118.0 (116.9–119.1) 2587 119.1 (118.0–120.2)
DBP (mmHg) 5174 74.9 (74.4–75.4) 2587 74.7 (74.0–75.4) 2587 75.1 (74.4–75.9)
FG (mgdl 1) 5153 86.6 (85.2–88.1) 2585 87.4 (85.4–89.2) 2568 85.9 (83.8–88.3)
TC (mgdl 1) 5124 86.6 (81.6–91.6) 2571 98.2 (91.3–105.6) 2553 74.6 (68.1–81.6)
TG (mgdl 1) 5118 137.3 (132.9–140.8) 2570 141.7 (136.4–147.03) 2548 132.0 (126.7–137.3)
Abbreviations: BMI, body mass index; Cl, confidence limits; DBP, diastolic blood pressure (mean of the two visits); FG, fasting plasma glucose (mean of the two
visits); SBP, systolic blood pressure (mean of the two visits); TC, Total cholesterol; TG, Triglycerides; W/H, waist-to-hip ratio. Data (education, anthropometric
parameters, blood pressure and laboratory values) are reported as the number of subjects who gave a response to the specific item(s), and mean value with
95% confidence limits. All values are weighted to the Yemen population aged 15–69 years in 2008.
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associated with proteinuria only in urban areas (Table 4). The
presence of proteinuria, however, did not affect hypertension
awareness, allocation to antihypertensive treatment or achieve-
ment of BP control (Table 3).
DISCUSSION
The common risk factors shared by kidney damage and
cardiovascular diseases support the focus on diabetes and
hypertension as an adequate strategy to deal with kidney damage
also in the developing countries. It is however intriguing to see
that in Yemen the prevalence of proteinuria is higher in the rural
areas compared with the urban areas.
According to the 2010 US Renal Data System Annual Data
Report,24 diabetes is the leading cause of ESRD in the United
States. The increasing number of people with diabetes in
developing countries due to population growth, aging,
urbanization,25 and increased prevalence of diabetes, obesity and
physical inactivity is expected to have profound negative effects on
global health. The broad package of prevention and screening
strategies implemented by the main Scientific Societies is thus
mainly focused to cope with the effects of globalization
(urbanization) on hypertension, diabetes and metabolic disease.5,26
Only minor attention is however paid to three aspects of kidney
damage, which might be relevant to the context of low-income
countries. First, the presence of proteinuria is a recognized marker
of cardiovascular risk.18 Proteinuria of trace or 1þ at dipstick test
was indeed found to be associated with an adjusted HR of 2.1 for
all-cause mortality, 2.7 for doubling of the serum creatinine level
and 1.7 for ESRD among individuals with initially normal estimated
glomerular-filtration rate.12 Proteinuria is a risk factor to develop
chronic kidney disease and eventually ESRD; the higher the
proteinuria the higher the risk.11 Recent evidence is also revealing
that kidney damage hazards (death, cardiovascular death and
ESRD) are independent of diabetes and hypertension.27,28 Second,
in China, where the prevalence of proteinuria is high,29
glomerulonephritis, mainly post-infectious, is the main cause of
end-stage kidney disease.30 In those communities, the dualism of
communicable and non-communicable disease is indeed deprived
of content, rheumatic heart disease being also a not negligible
cause of atrial fibrillation and stroke.31,32 Third, although in low-
income countries the possibility to treat ESRD may be limited,
early detection and treatment of kidney damage using readily
available, inexpensive therapies might slow down or prevent the
progression of renal disease.13 Therefore, the importance of
Table 2. Prevalence estimates of main investigated clinical conditions in all subjects and stratified by gender, and urban/rural locations
Variables All Urban Rural Odd ratio rural vs urban (95% Cl)
Unadjusted Adjusted
All
Hypertension 7.7 (7.2–8.1) 7.5 (6.8–8.1) 7.8 (7.2–8.5) 1.08 (0.96–1.21) 1.23 (1.08–1.41)
Diabetes 3.2 (2.9–3.5) 3.7 (3.3–4.2) 2.6 (2.2–3.0) 0.67 (0.56–0.80) 0.70 (0.58–0.85)
High cholesterol 10.8 (10.1–11.4) 14.0 (12.9–15.0) 7.6 (6.8–8.4) 0.47 (0.42–0.53) 0.46 (0.41–0.52)
Obesity 8.0 (7.4–8.5) 9.5 (8.7–10.4) 6.5 (5.8–7.1) 0.66 (0.58–0.75) 0.77 (0.66–0.89)
Abdominal obesity 10.9 (10.2–11.5) 12.6 (11.7–13.6) 9.1 (8.3–9.9) 0.66 (0.59–0.74) 0.72 (0.62–0.82)
Proteinuria 6.2 (5.6–6.8) 5.1 (4.4–5.9) 7.3 (6.4–8.1) 1.63 (1.38–1.93) 1.56 (1.31–1.86)
Men
Hypertension 6.7 (6.1–7.3) 7.0 (6.0–7.9) 6.5 (5.6–7.3) 1.01 (0.85–1.20) 1.06 (0.87–1.29)
Diabetes 2.9 (2.5–3.3) 3.5 (2.8–4.1) 2.4 (1.9–2.9) 0.70 (0.55–0.91) 0.77 (0.59–1.01)
High cholesterol 8.5 (7.7–9.4) 11.2 (9.9–12.5) 5.9 (4.9–6.8) 0.46 (0.38–0.55) 0.46 (0.38–0.55)
Obesity 5.4 (4.7–6.1) 6.0 (5.0–7.1) 4.8 (4.0–5.7) 0.86 (0.69–1.06) 1.07 (0.83–1.38)
Abdominal obesity 2.2 (1.8–2.6) 2.8 (2.2–3.4) 1.6 (1.1–2.0) 0.52 (0.38–0.72) 0.51 (0.35–0.75)
Proteinuria 7.0 (6.2–7.9) 5.6 (4.5–6.8) 8.5 (7.1–9.8) 1.79 (1.42–2.25) 1.76 (1.39–2.23)
Women
Hypertension 8.6 (7.9–9.3) 8.1 (7.1–9.0) 9.2 (8.2–10.2) 1.14 (0.97–1.34) 1.37 (1.14–1.65)
Diabetes 3.4 (3.0–3.9) 4.0 (3.4–4.7) 2.8 (2.2–3.4) 0.64 (0.50–0.82) 0.62 (0.48–0.81)
High cholesterol 13.0 (11.9–14.0) 16.6 (15.0–18.3) 9.3 (8.0–10.5) 0.48 (0.41–0.56) 0.46 (0.39–0.55)
Obesity 10.5 (9.7–11.4) 13.0 (11.6–14.4) 8.1 (7.0–9.1) 0.57 (0.49–0.67) 0.65 (0.54–0.79)
Abdominal obesity 19.5 (18.4–20.7) 22.5 (20.7–24.2) 16.6 (15.1–18.1) 0.65 (0.58–0.74) 0.73 (0.63–0.85)
Proteinuria 5.3 (4.6–6.1) 4.6 (3.7–5.6) 6.1 (5.0–7.2) 1.45 (1.13–1.86) 1.33 (1.03–1.73)
Abbreviation: Cl, confidence limits. Hypertension, systolic blood pressure X140mmHg or diastolic blood pressure X90mmHg at the two visits and/or self-
reported use of antihypertensive drugs at the time of the interview; diabetes, fasting blood glucose X126mgdl 1 at both the visits or self-reported use of
insulin or oral hypoglycaemic medications at the time of the interview; high cholesterol, total cholesterol 4190mgdl 1; obesity, body mass index
X30 kgm 2; abdominal obesity, waist circumference4102 cm in men and488 cm in women; Proteinuria,Xþ 1 at dipstick urinalysis. Age-weighted rates to
the 15–69-year-old Yemen population 2008 (mean, 95% Cl). Odds ratio (with 95% Cl) for the differences between rural and urban householders, unadjusted
and adjusted for age, gender, education categories, hypertension, diabetes, high cholesterol, obesity and abdominal obesity.
Table 3. Logistic regressiona of factors for the association with
hypertension awareness, pharmacologic treatment (including all the
1307 subjects with hypertension) and blood pressure (BP) drug control








Age (per decade) 1.19 (1.04–1.35) 1.23 (1.08–1.41) 0.71 (0.56–0.88)
Gender (women vs men) 1.29 (1.01–1.64) 1.31 (1.03–1.68) 1.75 (1.15–2.67)
Location (rural vs urban) 0.56 (0.45–0.71) 0.61 (0.48–0.76) 1.13 (0.77–1.65)
Education (per category) 0.92 (0.84–1.01) 0.91 (0.83–1.00) 1.06 (0.91–1.23)
Proteinuria (yes vs no) 1.20 (0.82–1.76) 1.34 (0.91–1.97) 0.57 (0.29–1.11)
Abbreviation: Cl, confidence limits. aAdjusted variables are age (decades),
gender, urban/rural location, education categories (illiterate, able to read
and write, primary school, secondary school, high school, college or more)
and proteinuria (Xþ 1 at dipstick urinalysis).
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Figure 1. Venn diagram showing the amount of overlap between hypertension, diabetes and proteinuria, separate for the subjects from the
urban and rural area. Data are expressed as percent of urban or rural subjects, the absolute number being reported in brackets.
Figure 2. Factors independently associated with proteinuria at logistic regression analysis including 9385 participants. Results are expressed as
OR with 95% Cl.
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focusing treatments on subjects at high risk is now recognized to
have potential implications for health-care resource allocation in
low-resource settings.13,14 Screening strategies based on BP
readings only were reported to overestimate the population at
risk. Hypertension prevalence based on BP readings obtained after
two visits is indeed 35% lower than the estimation based on the
first visit.14 The inclusion of urine dipstick test might be of help, as
only 1.9% of the subjects classified at high or very high
cardiovascular risk at visit 1 on the basis of BP readings and
urine dipstick test moved to average, low or moderate
cardiovascular risk categories after two visits.14 The results of the
present study add important information revealing that in
developing countries, a large number of subjects have
proteinuria in the absence of hypertension and diabetes in
agreement with observations performed in Nepal and Bolivia.10
Furthermore, in Yemen the prevalence of proteinuria is higher in
the rural areas compared with the urban areas. According to the
present findings obtained at the population level, the association
with rural location was present for proteinuria categories trace,
1þ , 2þ and 3þ , the lack of significant association for the
highest category (4þ ) being probably due to low numbers (seven
among rural and four among urban dwellers). In addition, diabetes
is associated with kidney injury only in urban areas, whereas the
association between hypertension and proteinuria is present
among both urban and rural residents. The relationship between
Figure 3. Factors independently associated with rural setting at logistic regression analysis including 9385 participants. Results are expressed
as OR with 95% Cl.
Table 4. Unadjusted and adjusted (logistic regressionsa,b) odds ratios
(OR) of factors associated with proteinuria among all participants
(including 10 242 subjects), and among urban (including 5109
subjects) or rural dwellers (including 5133 subjects)
Factors Unadjusted Adjusteda Adjustedb
OR (95% Cl) OR (95% Cl) OR (95% Cl)
All participants
Hypertension (yes vs no) 1.78 (1.45–2.19) 1.97 (1.56–2.48) 1.95 (1.54–2.47)
Diabetes (yes vs no) 1.71 (1.27–2.31) 1.60 (1.17–2.20) 1.62 (1.18–2.23)
Location (rural vs urban) 1.63 (1.38–1.93) 1.57 (1.32–1.86) 1.56 (1.31–1.86)
Age (per decade) 0.95 (0.90–1.01) 0.85 (0.79–0.91) 0.84 (0.78–0.91)
Urban
Hypertension (yes vs no) 1.68 (1.20–2.35) 1.95 (1.33–2.84) 1.95 (1.33–2.87)
Diabetes (yes vs no) 1.84 (1.20–2.81) 1.82 (1.15–2.88) 1.80 (1.13–2.87)
Age (per decade) 0.87 (0.79–0.95) 0.77 (0.68–0.86) 0.76 (0.68–0.86)
Rural
Hypertension (yes vs no) 1.82 (1.39–2.37) 1.95 (1.45–2.63) 1.91 (1.41–2.58)
Diabetes (yes vs no) 1.75 (1.14–2.67) 1.47 (0.95–2.30) 1.49 (0.96–2.33)
Age (per decade) 1.01 (0.94–1.09) 0.90 (0.82–0.99) 0.90 (0.82–0.99)
Abbreviation: Cl, confidence limits. aAdjusted variables are hypertension,
diabetes, urban/rural location, age, gender and education categories.
bAdjusted variables are hypertension, diabetes, urban/rural location, age,
gender, education categories, high cholesterol, obesity and abdominal
obesity.
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hypertension and proteinuria is however bidirectional, renal
disease being either a form of target organ damage or a
secondary cause of hypertension, and a condition frequently
associated with pre-existing primary kidney disease. After
adjustment, only proteinuria remained the single risk condition
that was more prevalent among rural residents. It is thus
conceivable that hypertension among rural residents might be
linked with pre-existing kidney disease. Difference between rural
and urban areas might also be caused by the disparity in health
care between the different areas of Yemen.33 According to the
present findings, awareness and treatment of hypertension were
substantially lower in rural areas than in urban areas, consistent
with previous results obtained in other countries.34 However, the
possibility to achieve hypertension control in Yemen, as also in
Iran,35 did not differ between urban and rural residents. Most
importantly, the absence of educational influence on hypertension
awareness, treatment and BP control (Table 3) indicates
that knowledge on cardiovascular prevention among Yemen
population is limited.
Our study had several limitations. First, the true rate of kidney
damage assessed by the presence of proteinuria might be lower
than that estimated, as proteinuria is to be confirmed with
repeated assessment, a procedure which was not adopted in the
present survey strategy. However, a similar reduction is expected
to occur independently in the urban or rural residency, so that this
methodological bias should not modify the main observation.
Furthermore, the same higher prevalence in rural than in urban
dwellers was observed for all proteinuria scores, high values being
less affected by test variability than trace levels. Second, the use of
dry chemistry for laboratory investigations could also be
considered a limitation in our study. However, the possibility to
have investigations carried out during a home visit could turn into
a great advantage when operating in developing countries. The
long distance to get to a service laboratory requires shipments
under special conditions, often resulting in deterioration and
spoilage of the specimen. In addition, all investigators completed
a certification program before the study, and quality-control
procedures were used during the study. Third, we did not collect
information regarding outdoor activity of participants, therefore,
we cannot exclude that urine of the rural dwellers could be more
concentrated. Measuring the urinary proteins/creatinine ratio
could have solved this problem.
Fourth, the definition of diabetes was based on FG measured at
the two visits, and oral glucose-tolerance test was not done.
However, the number of subjects with urinary glucose at dipstick
test was also higher among urban than rural dwellers. In addition,
measuring HbA1c, which could be done even in the field, could
perhaps have solved the underestimation of diabetes by only
measuring fasting samples. Finally, the cross-sectional design of
the study makes inference of a causal relationship between
indicators of kidney damage and associated factors impossible.
We recognize that in the absence of prospective studies
performed in low-resource settings, it is impossible to infer that
proteinuria, on a completely different background in rural settings
like this, should carry the same risk found in studies performed in
industrialized societies.
In conclusion, proteinuria is related to hypertension and
diabetes in the developed countries but not in Yemen, particularly
in the rural setting. The amount of overlap between hyper-
tension, diabetes and proteinuria indeed clearly indicates that the
majority of proteinuria is neither related to hypertension nor
diabetes as recently reported for other low-income countries.10
The inverse relationship between proteinuria and age compared
with other complications/risk factors also suggests a completely
different background. Notwithstanding these limitations, our
results clearly show that the approach of considering
kidney damage only as a consequence of cardiovascular
diseases (including hypertension) and diabetes might limit the
effectiveness of secondary prevention strategies, as well as of
health-promoting interventions, especially in low-income
countries.
What is known about the topic
 Changes in lifestyle and diet habits following urbanization are greatly
contributing to increase in the prevalence of cardiovascular disease in
developing countries.
 The common risk factors shared by kidney damage and cardiovascular
diseases support the focus on diabetes and hypertension as an
adequate strategy to deal with kidney damage also in the developing
countries.
 However, in countries at the earliest stages of epidemiological
transition, where the prevalence of post-infectious glomerulonephritis
is still high, little information is available on the different meanings of
proteinuria among urban and rural dwellers.
What this study adds
 The prevalence of proteinuria is higher in the rural areas of
Yemen compared with the urban areas. Proteinuria is independently
associated with diabetes only among urban dwellers, whereas
the association with hypertension was present in either urban or
rural dwellers. A prescreening phase including clinical history, BP and
biochemical measurements might be insufficient to identify and treat
those at risk for progressive renal disease.
 The approach of considering kidney damage as a consequence of
hypertension and diabetes might thus limit the effectiveness of
secondary prevention strategies, as well as of health-promoting
interventions in low-income countries.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
ACKNOWLEDGEMENTS
We thank the many enthusiastic workers in Yemen who have contributed to the
study: Capital area: Hisham Abdulrab Ali Al Qubati, Raed Faisal Nasser, Aziz Hussain
Ali Moshoeh, Mohammed Abdulah Ashmeni, Abdulhamed Hulfy Alanashany,
Mohammed Ibrahim Ahmed Al Hamali, Naif Radman Hamdan Agial, Sami Abduh
Kaid Ahmed Alwessaby, Munera Abduwhab Saleh Yahya, Hyam Abdul Kareem Al Hyfi,
Ziad Abdullah Mohammed Al Mass, Liza Nayib Shamiri, Sahar Ahmed Abdullah
Moqbel, Abdullah Assan Mohammed Guly, Abdulaziz Saeed Salem Bawazir,
Abi Saleh Al Rawi, Kaled Sadeg Ali Al-Shaibari, Abdul Bari Mahfoudh Omar Al Daba,
Osama Hadi Abdu Haig, Gamil Al Hamdi Abdo Mohsan; Inland area: Khalil
Abdulwahid Ali Al-Kuhlani, Fahd Ahmed Ahmed Ali Al Durafi, Moad Ahmed Abdul
Al Karem Al Shorihy, Ashra F Saheed Abdalh, Omar Ahmed Abdul Aziz, Kalil Abdu
Mohammed Assufi, Ahmed Saeed Ahmed Al Terin, Mamon Ahdo Alrahmen Alp, Fuad
Mohammed Ali Abdu Ghaleb, Mohammed Ali Hussen, Mobark Mohammad Dabwan
Quasem, Awad Hamad Mohammad; Coastal area: Yasin Mohammad Al Hay Ibrahim,
Abdu Al Aleem Qaid Abdu Al Aleem Safian, Mohammed Ali Mohammed Salman,
Abdh Kozim Abdullah Al Nhozy, Mohammed Awad Omer Hydhi, Hussein Omar Al
Ahbari, Adel Hai Bin Obedellah, Khalid Hussan Khaleby. We would also like to thank
the chiefs and elders of the villages for their help and HE Mario Boffo, former Italian
Ambassador to the Repubblic of Yemen, Vice-Director for North Africa and Middle
East of the Italian Ministry of Foreign Affairs for his assistance. HYDY Study Group:
Steering Committee: Pietro Amedeo Modesti (Chair), Husni Al Goshae, Mohamed
Bamoshmoosh, Dawood Al-Hidabi, Marzia Baldereschi, Stefano Rapi, Luciano
Massetti; Monitoring Board: Mohamed Shamsuddin, Hameed M Aklan, Mahdy Al-
Karewany, Abdul-Malik Al-Amrany, Ferdawsi Al-Jilani; Data Center: Ammar Al-Ghadi.
HYDY project is part of the Executive Program of Scientific and Technological
Cooperation between Italy and Yemen for the years 2006–2009. This Study was
supported by a grant from the Ministero dell’Universita` e della Ricerca (Direzione
Generale per le strategie e lo sviluppo dell’internazionalizzazione della ricerca
scientifica e tecnologica), Rome, Italy and Menarini International Operations
Luxembourg SA.
DISCLAIMER
The sponsor had no role in study design; collection, analysis and interpretation
of data; writing the report and the decision to submit the report for publication.
Proteinuria in urban and rural Yemen dwellers
PA Modesti et al
7
& 2013 Macmillan Publishers Limited Journal of Human Hypertension (2013), 1 – 8
REFERENCES
1 World Health Organization. Global Health Risks: Mortality and Burden of Disease
Attributable to Selected Major Risks. WHO: Geneva, 2009http://www.who.int/
healthinfo/global_burden_disease/global_health_risks/en/index.html(accessed 26
January 2012.
2 Ezzati M, Vander Hoorn S, Lawes CM, Leach R, James WP, Lopez AD et al.
Rethinking the ‘diseases of affluence’ paradigm: global patterns of nutritional risks
in relation to economic development. PLoS Med 2005; 2(5): e133.
3 Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global
burden of hypertension: analysis of worldwide data. Lancet 2005; 365:
217–223.
4 He FJ, Jenner KH, Macgregor GA. WASH-world action on salt and health. Kidney Int
2010; 78: 745–753.
5 Feehally J. Chronic kidney disease: health burden of kidney disease recognized by
UN. Nat Rev Nephrol 2011; 8: 12–13.
6 Eastwood JB, Corbishley CM, Grange JM. Tuberculosis and the kidney. J Am Soc
Nephrol 2001; 12: 1307–1314.
7 Bhamarapravati N, Boonpucknavig S, Boonpucknavig V, Yaemboonruang C.
Glomerular changes in acute plasmodium falciparum infection. An immuno-
pathologic study. Arch Pathol 1973; 96: 289–293.
8 Barsoum RS. Schistosomiasis and the kidney. Semin Nephrol 2003; 23: 34–41.
9 Perico N, Remuzzi G. Chronic kidney disease: a research and public health priority.
Nephrol Dial Transplant 2012; 27(Suppl 3): iii19–iii26.
10 Cravedi P, Sharma SK, Bravo RF, Islam N, Tchokhonelidze I, Ghimire M et al.
Preventing renal and cardiovascular risk by renal function assessment: insights
from a cross-sectional study in low-income countries and the USA. BMJ Open
2012; 2(5): e001357.
11 Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-
stage renal disease. Kidney Int 2003; 63: 1468–1474.
12 Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE et al.
Association of estimated glomerular filtration rate and albuminuria with all-cause
and cardiovascular mortality in general population cohorts: a collaborative meta-
analysis. Lancet 2010; 375: 2073–2081.
13 Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney
disease to the global burden of major noncommunicable diseases. Kidney Int
2011; 80: 1258–1270.
14 Modesti PA, Rapi S, Bamoshmoosh M, Baldereschi M, Massetti L, Padeletti L et al.
Impact of one or two visits strategy on hypertension burden estimation in HYDY,
a population-based cross-sectional study: implications for healthcare resource
allocation decision making. BMJ Open 2012; 2(4): e001062.
15 Gunaid AA. Prevalence of known diabetes and hypertension in the Republic of
Yemen. East Mediterr Health J 2002; 8: 374–385.
16 Gunaid AA, Assabri AM. Prevalence of type 2 diabetes and other cardiovascular
risk factors in a semirural area in Yemen. East Mediterr Health J 2008; 14:
42–56.
17 US Census Bureau: International Data Base (IDB),Yemen 2008. http://www.cen-
sus.gov/ipc/www/idb/groups.php (accessed 8 November 2012).
18 Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al.
Management of Arterial Hypertension of the European Society of Hypertension;
European Society of Cardiology. 2007 Guidelines for the Management of Arterial
Hypertension: The Task Force for the Management of Arterial Hypertension of the
European Society of Hypertension (ESH) and of the European Society of Cardi-
ology (ESC). J Hypertens 2007; 25: 1105–1187.
19 Rapi S, Bazzini C, Tozzetti C, Sbolci V, Modesti PA. Point-of-care testing of cho-
lesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in
system. Transl Res 2009; 153: 71–76.
20 Rapi S, Bartolini L, Puliti D, Cambi GE, Bamoshmoosh M, Baldereschi M et al.
Conventional dipsticks in the screening of microalbuminuria and urinary tract
infections. Killing 2 birds with one stone? Saudi Med J 2010; 31: 708–709.
21 American Diabetes Association. Diagnosis and classification of diabetes mellitus.
Diabetes Care 2008; 31: S55–S60.
22 Modesti PA, Massetti L, Bamoshmoosh M, Baldereschi M, Cambi GE, Rapi S. The
impact of fine-tuning of optical recognition system on database reliability.
Comput Biol Med 2012; 42: 778–783.
23 Ahmad O, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age stan-
dardization of rates: a new WHO standard. GPE Discussion Paper Series: No. 31,
World Health Organization, 2001 http://www.who.int/healthinfo/paper31.pdf
(accessed 8 November 2012).
24 Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A et al. US renal data
system 2010 annual data report. Am J Kidney Dis 2011; 57(Suppl 1): A8, e1–526.
25 Kennedy DP, Adolphs R. Stress and the city. Nature 2011; 474: 452–453.
26 Sacco RL, Smith SC, Holmes D, Shurin S, Brawley O, Cazap E et al. Accelerating
progress on non-communicable diseases. Lancet (e-pub ahead of print 19
September 2011; doi:10.1016/S0140-6736(11)61477-3).
27 Fox CS, Matsushita K, Woodward M, Bilo HJ, Chalmers J, Heerspink HJ et al.
Associations of kidney disease measures with mortality and end-stage renal
disease in individuals with and without diabetes: a meta-analysis. Lancet 2012;
380(9854): 1662–1673.
28 Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T et
al. Associations of kidney disease measures with mortality and end-stage renal
disease in individuals with and without hypertension: a meta-analysis. Lancet
2012; 380(9854): 1649–1661.
29 Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J et al. Prevalence of chronic kidney
disease in China: a cross-sectional survey. Lancet 2012; 379: 815–822.
30 Dialysis and Transplantation Registration Group CSoNCMA. The report about the
registration of dialysis and transplantation in China 1999. Chin J Nephrol 2001; 17:
77–78.
31 Zhou Z, Hu D, Chen J, Zhang R, Li K, Zhao X. An epidemiological survey of atrial
fibrillation in China. Chin J Intern Med 2004; 43: 491–494.
32 Wang D, Liu M, Hao Z, Tao W, Lin S, Zhang S et al. Features of acute ischemic
stroke with rheumatic heart disease in a hospitalized Chinese population. Stroke
2012; 43: 2853–2857.
33 Hurtado A, Johnson RJ. Hygiene hypothesis and prevalence of glomerulone-
phritis. Kidney Int Suppl 2005; 97: S62–S67.
34 Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C et al. Prevalence, awareness, treatment,
and control of hypertension in China: data from the China National Nutrition and
Health Survey 2002. Circulation 2008; 118: 2679–2686.
35 Ebrahimi M, Mansournia MA, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A
et al. Social disparities in prevalence, treatment and control of hypertension in
Iran: second National Surveillance of Risk Factors of Noncommunicable Diseases,
2006. J Hypertens 2010; 28: 1620–1629.
This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivs 3.0 Unported License. To view a copy of
this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
Supplementary Information accompanies this paper on the Journal of Human Hypertension website (http://www.nature.com/jhh)
Proteinuria in urban and rural Yemen dwellers
PA Modesti et al
8
Journal of Human Hypertension (2013), 1 – 8 & 2013 Macmillan Publishers Limited
